ANDA 89521, held by Hospira. Phenytoin Sodium.
As of Nov 16, 2026, ANDA 89521 (Phenytoin Sodium), held by Hospira, was first approved by FDA on Mar 17, 1987, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 17, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phenytoin Sodium50MG/ML ยท injectable;injection | Phenytoin Sodium | Discontinued |
| Jan 29, 2014 | Supplement 11Labeling | Approved | None posted |
| Nov 30, 1995 | Supplement 3Manufacturing | Approved | None posted |
| Jun 6, 1994 | Supplement 2Manufacturing | Approved | None posted |
| Nov 12, 1991 | Supplement 1Labeling | Approved | None posted |
| Mar 17, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters